Business / Finance

RSS

YM BioSciences reports revenue of $0.3 million for first quarter 2012

YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer-related products, today reported operational and financial results for its first quarter of fiscal 2012, ended September 30, 2011.

11 Nov 2011

China Pharma third quarter revenue increases 12% to $21.0 million

China Pharma Holdings, Inc., a specialty pharmaceuticals company in China, today announced financial results for the quarter ended September 30, 2011.

11 Nov 2011

FarmaSyn implements Cegedim Relationship Management's Mobile Intelligence for iPad solution

Cegedim Relationship Management today announced that FarmaSyn SA has fully deployed Cegedim Relationship Management's award winning Mobile Intelligence for iPad™ solution. Farmasyn SA is a leading Greek pharmaceutical wholesaler and marketing/sales agent of products.

10 Nov 2011

GenMark Diagnostics third quarter revenues increase 90% to $1.3 million

GenMark Diagnostics, Inc. today reported financial results for the third quarter ended September 30, 2011.

10 Nov 2011

Emdeon third quarter revenue increases 14.7% to $282.1 million

Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced financial results for the third quarter ended September 30, 2011.

10 Nov 2011

DATATRAK third quarter revenue increases 13% to $2.1 million

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its operating results for the third quarter of 2011.

10 Nov 2011

Span-America fourth quarter sales decrease 1% to $13.7 million

Span-America Medical Systems, Inc. today reported its results for the fourth quarter and fiscal year ended October 1, 2011. The company reported fourth quarter 2011 sales of $13.7 million and net income of $910,000, or $0.32 per diluted share. Sales for fiscal year 2011 were $52.6 million, and net income was $3.7 million, or $1.30 per diluted share.

10 Nov 2011

Obagi Medical Products third quarter net income increases to $4.4M

Obagi Medical Products, Inc., a leader in topical aesthetic and therapeutic skin health systems, today reported financial results for the third quarter and nine months ended September 30, 2011.

10 Nov 2011

PDI third quarter revenues increase 4% to $37.2 million

PDI, Inc., today reported financial and operational results for the third quarter ended September 30, 2011.

10 Nov 2011

Transgenomic third quarter total revenue increases 87% to $8.3 million

Transgenomic, Inc. today reported financial results for the three and nine months ended September 30, 2011 and provided a business update.

10 Nov 2011

AxoGen third quarter revenues increase 42.5% to $1.1 million

AxoGen, Inc. today reported third quarter of 2011 revenues of $1.1 million, a 42.5% increase over $0.8 million reported during the third quarter of 2010.

10 Nov 2011

Kanghui third quarter total net revenue increases 26.9% to RMB80.7M

China Kanghui Holdings, a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced financial results for the third quarter of 2011.

10 Nov 2011

LGL third quarter total revenues decrease 22.3% to $9,629,000

The LGL Group, Inc., announced results for the quarter ended September 30, 2011.

9 Nov 2011

BioSante third quarter net loss increases to $12.7 million

BioSante Pharmaceuticals, Inc. today announced financial results for the third quarter ended September 30, 2011 and provided an update on the Company's pipeline.

9 Nov 2011

ACADIA third quarter revenues decrease to $584,000

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the third quarter ended September 30, 2011.

9 Nov 2011

Ventas to receive $125 million as lawsuit settlement from HCP

Ventas, Inc. today announced that HCP, Inc. has agreed to pay it $125 million to settle the Company's outstanding lawsuit against HCP arising out of the Company's 2007 acquisition of Sunrise Senior Living REIT.

9 Nov 2011

Idera third quarter net loss increases to $5.5 million

Idera Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2011. Idera is a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like receptors (TLRs).

9 Nov 2011

Accretive Health third quarter net services revenue increases 38% to $218.9 million

Accretive Health, Inc., a leading provider of comprehensive end-to-end healthcare revenue cycle management services and population health management services infrastructure, today announced financial results for the third quarter ended September 30, 2011.

9 Nov 2011

BioClinica third quarter service revenues increase 4.1% to $16.6 million

BioClinica, Inc., a global provider of clinical trial management and technology solutions, today announced its financial results for the third quarter and nine months ended September 30, 2011.

From Clario 9 Nov 2011

Salix to acquire Oceana Therapeutics

Oceana Therapeutics LLC, a privately owned global company focused on commercializing best-in-class specialty therapeutics, today announced it has entered into a definitive agreement for the sale of its operating subsidiary, Oceana Therapeutics, Inc. to Salix Pharmaceuticals, Ltd. of Raleigh, NC.

9 Nov 2011